GlassScriptPhysician profile
Phillip Michael Grob
NPI 1588725253
$3,436.86
in general payments reported to CMS, 2019-2025
16 companies · $404 in 2025
The $404 reported for 2025 was more than what a typical Geriatric Psychiatry provider received nationally (typical 2025 total: $125).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.96 · 2020: $12.45 · 2021: $508 · 2022: $767 · 2023: $1,152 · 2024: $546 · 2025: $404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,101.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $1,159.30 | 2019-2025 | Ingrezza |
| Abbvie INC. | $738.38 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $347.85 | 2021-2025 | Austedo, Uzedy, Austedo Xr |
| Janssen Pharmaceuticals, INC | $241.66 | 2021-2023 | Invega Trinza, Invega Sustenna, Spravato |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $198.97 | 2021-2024 | Caplyta |
| Alkermes, INC. | $156.56 | 2021-2024 | Aristada, Lybalvi |
| Indivior INC. | $146.78 | 2021-2024 | Perseris |
| Otsuka America Pharmaceutical, INC. | $141.48 | 2023-2025 | Rexulti, Abilify Maintena |
| Vanda Pharmaceuticals INC. | $70.60 | 2022-2023 | Hetlioz, Fanapt |
| Lundbeck LLC | $61.28 | 2023-2024 | Abilify Asimtufii, Abilify Maintena |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $60.83 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $52.83 | 2024-2025 | Cobenfy |
| Allergan, INC. | $17.50 | 2019 | |
| Sunovion Pharmaceuticals INC. | $17.02 | 2022 | |
| Axsome Therapeutics, INC. | $13.37 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $12.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Grob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.